172 related articles for article (PubMed ID: 33125138)
1. Anti‑EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomas.
Kaneko MK; Ohishi T; Takei J; Sano M; Nakamura T; Hosono H; Yanaka M; Asano T; Sayama Y; Harada H; Kawada M; Kato Y
Oncol Rep; 2020 Dec; 44(6):2517-2526. PubMed ID: 33125138
[TBL] [Abstract][Full Text] [Related]
2. A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
Takei J; Kaneko MK; Ohishi T; Hosono H; Nakamura T; Yanaka M; Sano M; Asano T; Sayama Y; Kawada M; Harada H; Kato Y
Oncol Rep; 2020 Nov; 44(5):1949-1960. PubMed ID: 33000243
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activities of a defucosylated anti‑EpCAM monoclonal antibody in colorectal carcinoma xenograft models.
Li G; Suzuki H; Ohishi T; Asano T; Tanaka T; Yanaka M; Nakamura T; Yoshikawa T; Kawada M; Kaneko MK; Kato Y
Int J Mol Med; 2023 Feb; 51(2):. PubMed ID: 36660940
[TBL] [Abstract][Full Text] [Related]
4. Anti‑EGFR monoclonal antibody 134‑mG2a exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
Hosono H; Takei J; Ohishi T; Sano M; Asano T; Sayama Y; Nakamura T; Yanaka M; Kawada M; Harada H; Kaneko MK; Kato Y
Int J Mol Med; 2020 Oct; 46(4):1443-1452. PubMed ID: 32945346
[TBL] [Abstract][Full Text] [Related]
5. The anti-epithelial cell adhesion molecule (EpCAM) monoclonal antibody EpMab-16 exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
Hosono H; Ohishi T; Takei J; Asano T; Sayama Y; Kawada M; Kaneko MK; Kato Y
Oncol Lett; 2020 Dec; 20(6):383. PubMed ID: 33154781
[TBL] [Abstract][Full Text] [Related]
6. Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
Asano T; Ohishi T; Takei J; Nakamura T; Nanamiya R; Hosono H; Tanaka T; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184091
[TBL] [Abstract][Full Text] [Related]
7. An anti‑TROP2 monoclonal antibody TrMab‑6 exerts antitumor activity in breast cancer mouse xenograft models.
Tanaka T; Ohishi T; Asano T; Takei J; Nanamiya R; Hosono H; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013368
[TBL] [Abstract][Full Text] [Related]
8. ChLpMab-23: Cancer-Specific Human-Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity.
Kaneko MK; Nakamura T; Kunita A; Fukayama M; Abe S; Nishioka Y; Yamada S; Yanaka M; Saidoh N; Yoshida K; Fujii Y; Ogasawara S; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):104-112. PubMed ID: 28504613
[TBL] [Abstract][Full Text] [Related]
9. Defucosylated mouse‑dog chimeric anti‑HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors.
Suzuki H; Ohishi T; Asano T; Tanaka T; Saito M; Mizuno T; Yoshikawa T; Kawada M; Kaneko MK; Kato Y
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856438
[TBL] [Abstract][Full Text] [Related]
10. A defucosylated anti-PD-L1 monoclonal antibody 13-mG
Takei J; Ohishi T; Kaneko MK; Harada H; Kawada M; Kato Y
Biochem Biophys Rep; 2020 Dec; 24():100801. PubMed ID: 32923698
[TBL] [Abstract][Full Text] [Related]
11. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody (134-mG
Nanamiya R; Takei J; Ohishi T; Asano T; Tanaka T; Sano M; Nakamura T; Yanaka M; Handa S; Tateyama N; Harigae Y; Saito M; Suzuki H; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Feb; 41(1):1-7. PubMed ID: 35225663
[TBL] [Abstract][Full Text] [Related]
12. Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.
Itai S; Ohishi T; Kaneko MK; Yamada S; Abe S; Nakamura T; Yanaka M; Chang YW; Ohba SI; Nishioka Y; Kawada M; Harada H; Kato Y
Oncotarget; 2018 Apr; 9(32):22480-22497. PubMed ID: 29854293
[TBL] [Abstract][Full Text] [Related]
13. Antiglycopeptide Mouse Monoclonal Antibody LpMab-21 Exerts Antitumor Activity Against Human Podoplanin Through Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity.
Kato Y; Kunita A; Fukayama M; Abe S; Nishioka Y; Uchida H; Tahara H; Yamada S; Yanaka M; Nakamura T; Saidoh N; Yoshida K; Fujii Y; Honma R; Takagi M; Ogasawara S; Murata T; Kaneko MK
Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):20-24. PubMed ID: 28234556
[TBL] [Abstract][Full Text] [Related]
14. A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG
Asano T; Tanaka T; Suzuki H; Li G; Ohishi T; Kawada M; Yoshikawa T; Kaneko MK; Kato Y
Antibodies (Basel); 2022 Nov; 11(4):. PubMed ID: 36546899
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro.
Sawatani Y; Komiyama Y; Nakashiro KI; Uchida D; Fukumoto C; Shimura M; Hasegawa T; Kamimura R; Hitomi-Koide M; Hyodo T; Kawamata H
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878053
[TBL] [Abstract][Full Text] [Related]
17. Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
Richter CE; Cocco E; Bellone S; Bellone M; Casagrande F; Todeschini P; Rüttinger D; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Int J Gynecol Cancer; 2010 Dec; 20(9):1440-7. PubMed ID: 21370592
[TBL] [Abstract][Full Text] [Related]
18. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines.
Harada K; Ferdous T; Kobayashi H; Ueyama Y
Int J Oncol; 2014 Dec; 45(6):2439-45. PubMed ID: 25230791
[TBL] [Abstract][Full Text] [Related]
20. Exchanging human Fcgamma1 with murine Fcgamma2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model.
Lutterbuese P; Brischwein K; Hofmeister R; Crommer S; Lorenczewski G; Petersen L; Lippold S; da Silva A; Locher M; Baeuerle PA; Schlereth B
Cancer Immunol Immunother; 2007 Apr; 56(4):459-68. PubMed ID: 16937114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]